Background: Few studies from the general population have investigated the role of anxiety in reporting dyspnoea. We examined the independent and combined association of lung function and anxiety symptoms with the prevalence of dyspnoea in different situations. Methods: The study included 5627 women and 5066 men who participated in the Lung study of the Nord-Trøndelag Health Study second survey in 1995e97. In a cross-sectional design we used logistic regression to calculate adjusted odds ratios (ORs) for reporting dyspnoea associated with levels of percent predicted FEV 1 (ppFEV 1 ) and anxiety (Hospital Anxiety and Depression Scale). Results: Overall, there was a linear inverse association between ppFEV 1 and dyspnoea (all P trend < 0.001), and a positive association between anxiety symptoms and dyspnoea (all P trend < 0.001). In combined analysis, using people with ppFEV 1 100 without anxiety as reference, the OR (95% confidence interval) for reporting dyspnoea when walking on flat ground was 6.23 (3.45e11.28) in women with ppFEV 1 <80 without anxiety and 15.14 (7.13e32.12) in women with ppFEV 1 <80 with anxiety. The corresponding ORs among men were 5.75 (2.23 e14.18) and 15.19 (4.74e48.64), respectively. Similar patterns were seen for dyspnoea when sitting still and woken at night by dyspnoea. Conclusion: Impaired lung function and anxiety symptoms were independently associated with reporting dyspnoea. Within lung function levels, reporting dyspnoea was more common among people with anxiety symptoms than among people without. This suggests that, in addition to its relation to reduced lung function, the subjective experience of breathing discomfort may also influence or be influenced by anxiety. ª
Introduction
The prevalence and burden of obstructive lung diseases are increasing. 1, 2 Lung function measurements, in particular forced expiratory volume in one second (FEV 1 ), are important in the diagnosis of asthma and chronic obstructive pulmonary disease (COPD) and in the physiological staging of COPD. 1, 2 However, dyspnoea and anxiety, which are common symptoms among people with obstructive lung diseases, 2e4 have been found to explain more of the variation in subjective health status of people with COPD than physiological variables like FEV 1 . 5 Studies from the general population suggest that dyspnoea has a stronger association with health-related quality of life than lung function, 6, 7 whereas FEV 1 has been reported to correlate weakly with dyspnoea in people with COPD. 8 Dyspnoea is a subjective experience of breathing discomfort 9 and a prominent symptom of asthma and COPD.
1,2 However, dyspnoea is also a symptom of anxiety, especially in people with panic disorder or hyperventilation syndrome. 3 Some studies have found associations between anxiety and dyspnoea independent of FEV 1 , 10e12 also in people with normal lung function. 13 This indicates that anxiety may explain some of the variation in reported dyspnoea that is not explained by FEV 1 .
Previous studies linking lung function, anxiety, and dyspnoea are mainly limited to people with specific diagnoses like asthma and COPD. 14, 15 However, a few studies from the general population have found associations between psychological and respiratory symptoms. 11, 13, 15, 16 The aim of this large epidemiologic study from a general population was to examine the independent and combined association of objectively measured lung function and reported anxiety symptoms with the prevalence of dyspnoea in different situations.
Methods

Study population
All residents of Nord-Trøndelag County in Norway aged 20 years or more were invited to the second survey of the large population-based Nord-Trøndelag Health Study (HUNT 2) between 1995 and 1997. HUNT 2 has been described in detail elsewhere. 17 Among the 65,215 participants who attended the primary screening (69.5% of those invited), about 20% were invited to the Lung study due to limited capacity for spirometric measurements at the screening station. The Lung study consisted of a 5% random sample and a symptom sample. 18, 19 The symptom sample included subjects reporting attacks of wheezing or breathlessness during the last 12 months, having ever had asthma, and/or having ever used asthma medication, and who were not included in the random sample. A flow chart of inclusion and exclusion in the Lung study is presented in Fig. 1 . Among the 13,518 individuals invited to perform spirometry, 10,848 (80.2%) had acceptable spirometry at the screening station. However, further quality assurance revealed 29 unacceptable spirometric measurements, and these were excluded from the analyses. In addition, 126 subjects were excluded due to misclassification. The analyses included the remaining 10,693 subjects, and these were weighted to represent 53,196 subjects from the general population of NordTrøndelag County.
Study variables
All participants in HUNT 2 filled in a general questionnaire on life style factors, complaints, and diseases. 19 Demographic data were recorded. Participants in the Lung study completed an additional lung specific questionnaire and an interview, 19 and performed flow volume spirometry.
Dyspnoea
We used measures of dyspnoea during three different situations; a) dyspnoea when walking on flat ground, b) dyspnoea when sitting still, and c) woken at night by dyspnoea. The lung-specific questionnaire included four questions about dyspnoea at various activities with "yes" or "no" as possible answers: Q1 "Do you become more short of breath than people your age when walking uphill?", Q2 "Do you become short of breath when you climb two flights of stairs at normal pace?", Q3 "Do you become short of breath when walking on flat ground at a normal pace?", and Q4 "Are you short of breath when sitting still?" These questions were included in the Norwegian respiratory questionnaire 20, 21 and have been used in Norwegian epidemiologic studies. 17, 21 The four questions were combined to a scale (25.7% missing), and cut-off was set at "yes" for Q3 (dyspnoea when walking on flat ground) or Q4 (dyspnoea when sitting still) which approximates dyspnoea grades 2 and 4, respectively, according to the modified British Medical Research Council dyspnoea scale. 22 In the interview the participants were asked "Have you woken at night because you were short of breath in the last 12 months?" Those answering "yes" were classified as woken at night by dyspnoea (0.47% missing).
Lung function
Flow volume spirometry was recorded according to the 1994 ATS recommendations 23 using three pneumotachographs (MasterScope Spirometer version 4.15, Erich Jaeger GmbH, Wuerzburg, Germany). 19 The spirometric measurements and quality control in the Lung study are described in detail elsewhere. 18 Pre-bronchodilator forced vital capacity (FVC) and FEV 1 were obtained, and local prediction equations were used. 18 Lung function was defined in two ways; first percent predicted FEV 1 (ppFEV 1 ) was categorised as 100.0, 80.0e99.9, 50.0e79.9, and <50.0; then COPD was defined as FEV 1 /FVC <70% and categorised according to modified Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria 2 as stage 1 (ppFEV 1 80), stage 2 (50 ppFEV 1 < 80), and stage 3 or 4 (ppFEV 1 < 50). Normal was defined as FEV 1 /FVC 70% and percent predicted FVC 80, and those with possible restriction (FEV 1 /FVC 70% and percent predicted FVC <80) were excluded from these analyses. In the analysis of the combined association of lung function and anxiety with dyspnoea, the latter two groups of lung function were collapsed to increase statistical power.
Anxiety
A Norwegian translation of the Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety. 24 Although the HADS questionnaire was originally developed to measure anxiety and depression in non-psychiatric patients treated in hospitals, it has also been reported to be valid when used in the general population. 25, 26 The HADS consists of 14 questions of which seven measure symptoms of anxiety and seven measure symptoms of depression during the past week. Each question is given a score of 0e3, and the total score for each subscale ranges from 0 to 21. A score of 0e7 indicates normal state, 8e10 borderline state, and 11e21 anxiety state. 26 Psychometric properties of the HADS have been thoroughly tested. 25, 27 When one or two answers were missing, the total score was extrapolated by multiplying the sum by 7/6 or 7/5, respectively. In the main analyses anxiety was categorized into three groups; no anxiety (HADS 0e7), borderline (HADS 8e10), and anxiety (HADS 11e21); whereas in the analysis of the combined association of lung function and anxiety, the latter two groups were collapsed into one anxiety symptoms category (HADS 8e21) to increase statistical power. When anxiety was entered as a possible confounder to the association between lung function and dyspnoea, people with missing data on three or more HADS questions (5.92%) were included in a separate category labelled unknown.
Statistical analyses
To enhance the generalizability of our results the regression analyses were weighted to reflect the distribution in the general population. We used an inverse probability weight 28 according to whether the participants were recruited through the symptom or the random sample. A weight of one was assigned to all included through the symptom sample and those in the random sample who fulfilled the inclusion
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Due to misclassification criteria for the symptom sample. The remaining participants of the random sample were assigned a weight of 20 (as 20 is the inverse of 5%). We also performed sensitivity analyses including subjects from the random sample only.
All analyses were conducted sex specific. 29 Logistic regression was used to compute adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for three separate outcomes; a) dyspnoea when walking on flat ground, b) dyspnoea when sitting still, and c) woken at night by dyspnoea. First, we estimated the adjusted ORs for the three outcomes within levels of lung function (ppFEV 1 or COPD stages) using the highest lung function level as reference. Trend tests across ppFEV 1 levels were conducted using the sex specific median value within each ppFEV 1 level as an ordinal variable in the regression model. Trend tests across COPD stages were conducted using the stages as an ordinal variable. Second, we calculated ORs for the three dyspnoea outcomes associated with anxiety using no anxiety as reference. Linear trend across the anxiety categories was assessed using the categories as an ordinal variable. Third, joint categories of lung function (ppFEV 1 or COPD stages) and anxiety were used to estimate the combined association to the three dyspnoea measures using the highest category of lung function without anxiety as the reference category.
All estimated associations were adjusted for potential confounding with age (<40.0, 40.0e49.9, ., 80.0), body mass index (BMI) (<18.5, 18.5e24.9, 25.0e29.9, 30.0 kg/ m 2 ), smoking history (never smoker, former smoker and <15 pack-years, former smoker and 15 pack-years, current smoker and <15 pack-years, current smoker and 15 pack-years, unknown [5.26%]), educational level (<10, 10e12, 13 years, unknown [5.63%]), and physical activity (inactive, light activity <1 h per week, light activity 1e2 h per week, light activity 3 h per week, only vigorous activity, unknown [11.76%] ). Additionally, lung function and anxiety were mutually adjusted when assessing their independent association with the dyspnoea measures. Age and BMI were entered as categorical variables in the regression models to avoid possible residual confounding due to non-linear associations. In separate analyses we additionally adjusted for depression (HADS 0e7, 8e10, 11e21, unknown) when studying the association between anxiety and dyspnoea.
All statistical tests were two-sided using 
Results
Baseline characteristics
In general, people with low levels of ppFEV 1 were characterised by older age, less education, more inactivity, and a higher proportion was ever smokers (Table 1) . Moreover, mean BMI was lowest among those with ppFEV 1 <50. The prevalence of anxiety and depression symptoms increased with lower ppFEV 1 among women. Baseline characteristics of the subjects among the random, symptom, and weighted samples are presented in Table S1 in the online supplement. The prevalence and mean of key variables did not differ much between the random and the weighted sample.
Lung function in association with dyspnoea
The adjusted ORs for reporting dyspnoea when walking on flat ground, dyspnoea when sitting still, and woken at night , smoking history (never smoker, former smoker and <15 pack-years, former smoker and 15 pack-years, current smoker and <15 pack-years, current smoker and 15 pack-years, unknown), educational level (<10, 10-12, 13 years, unknown), and physical activity (inactive, light activity <1 hours per week, light activity 1-2 hours per week, light activity 3 hours per week, only vigorous activity, unknown).
by dyspnoea increased with lower ppFEV 1 (Table 2) or higher COPD stage (Table S2 ) (all P trend < 0.002). Women with ppFEV 1 50e79 had an OR of 5.24 (95% CI 3.04e9.03) for dyspnoea when walking on flat ground compared to women with ppFEV 1 100, whereas the corresponding association among men was 4.00 (95% CI 1.67e9.59) ( Table 2) .
Anxiety in association with dyspnoea
The adjusted ORs for reporting dyspnoea when walking on flat ground, dyspnoea when sitting still, and woken at night by dyspnoea increased with increasing anxiety symptoms (all P trend < 0.001) ( Table 3) . Women with anxiety (HADS 11e21) had an OR of 3.39 (95% CI 1.95e5.88) for dyspnoea when walking on flat ground compared to women without anxiety (HADS 0e7), whereas the corresponding association among men was 3.88 (95% CI 1.77e8.50).
In general, having anxiety symptoms increased the adjusted ORs for reporting dyspnoea within ppFEV 1 levels (Table 4) or COPD stages (Table S3 ). This trend was most evident when lung function was measured as ppFEV 1 . Compared to women with ppFEV 1 100 without anxiety (HADS 0e7), women with ppFEV 1 80e99 without anxiety had an OR of 2.46 (95% CI 1.25e4.83) for dyspnoea when walking on flat ground, whereas women with ppFEV 1 80e99 with anxiety symptoms (HADS 8e21) had an OR of 7.71 (95% CI 3.65e16.28) for the same outcome ( Table 4 ). The corresponding associations among men were 1.10 (95% CI 0.44e2.73) and 5.17 (95% CI 1.88e14.24), respectively. Further adjustments for depression did not change the results (data not shown).
Sensitivity analyses
In general, the results from the analyses restricted to the random sample were comparable to the results from the weighted analyses of the total sample (Tables S4eS6). However, the estimates were imprecise due to few participants in the random sample.
Discussion
In this cross-sectional study from a general population, we found lung function and anxiety to be independently associated with dyspnoea when walking on flat ground, dyspnoea when sitting still, and woken at night by dyspnoea. Within lung function levels, reporting dyspnoea was more common among people with anxiety symptoms than among people without.
Lung function in association with dyspnoea
Another cross-sectional study from the general population has also found an association between airflow limitation and dyspnoea. 30 In-line with this, dyspnoea has been found to discriminate between people with and without bronchial obstruction. 31 The association between lung function and dyspnoea in people with asthma and COPD is not consistent. Weak correlations have been found between FEV 1 and asthma symptoms in asthma patients in general practice, 12 and between FEV 1 and dyspnoea in patients with COPD. 8 On the 2 ), smoking history (never smoker, former smoker and <15 pack-years, former smoker and 15 packyears, current smoker and <15 pack-years, current smoker and 15 pack-years, unknown), educational level (<10, 10e12, 13 years, unknown), and physical activity (inactive, light activity <1 h per week, light activity 1e2 h per week, light activity 3 h per week, only vigorous activity, unknown). Table 4 Weighted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) for reporting dyspnoea when walking on flat ground, dyspnoea when sitting still, and woken at night by dyspnoea according to joint categories of lung function and anxiety. , smoking history (never smoker, former smoker and <15 pack-years, former smoker and 15 pack-years, current smoker and <15 pack-years, current smoker and 15 pack-years, unknown), educational level (<10, 10e12, 13 years, unknown), and physical activity (inactive, light activity <1 h per week, light activity 1e2 h per week, light activity 3 h per week, only vigorous activity, unknown).
other hand, Schlecht et al. 32 found a clear association between low FEV 1 and severe dyspnoea in people with COPD. These inconsistent findings may be due to the limited ability of FEV 1 to reflect hyperinflation. Hyperinflation is one of the main causes of dyspnoea in people with obstructive lung diseases. 8 Dyspnoea may also be a result of abnormalities in respiratory muscles, blood-gases, ventilatory impedance, breathing patterns, or inability to adapt to heightened ventilatory demands.
9 FEV 1 does not necessarily reflect this.
Anxiety in association with dyspnoea
A few other studies have used data from the general population when studying the influence of psychological status on respiratory symptom reporting taking lung function into account. 11, 13, 16 When studying 600 "healthy" neversmokers between 14 and 55 years of age without any respiratory or other major diseases and with normal lung function, Dales et al. 13 found a strong positive association between anxiety and dyspnoea. This was supported by Janson et al. 16 who also found a clear association between anxiety and dyspnoea in a cross-sectional epidemiologic study. In their review from 2005 Chetta et al. 15 concluded that subjects with more psychological symptoms are more likely to report respiratory symptoms.
Similar associations have also been found among people with asthma and COPD. 10, 12 Among patients with asthma in general practice, anxiety has been found to help explain symptoms more than lung function and asthma severity. 12 Also Giardino et al. 10 found an association between anxiety and shortness of breath after adjusting for lung function in patients with emphysema.
The cause-and-effect relationships between anxiety and dyspnoea are unclear. 9 Bailey suggests that dyspnoea may cause anxiety, and anxiety may cause further dyspnoea, and she refers to this as a dyspnoeaeanxietyedyspnoea cycle. 33 However, findings from a prospective population-based study suggest that psychological symptoms like anxiety may cause dyspnoea. 11 In people with COPD, anxiety may cause dyspnoea by increasing respiratory rate and thereby reducing expiration time leading to worse hyperinflation. 8 Since we controlled for ppFEV 1 in our models, it is unlikely that the observed association between anxiety and dyspnoea could be explained by differences in ppFEV 1 .
Although we found anxiety symptoms to be associated with reporting dyspnoea in three different situations, the cause-and-effect relationship between anxiety and dyspnoea may differ depending on the situation in which dyspnoea is experienced. One might suspect that anxiety could cause dyspnoea when sitting still, and that experiencing dyspnoea when walking on flat ground or waking up with dyspnoea could cause anxiety. However, the current crosssectional study cannot confirm these speculations, and this needs to be further studied in other study designs.
To distinguish anxiety and depression, which often coexist, 34 we adjusted for depression in separate analyses. Since this did not change our results, it is unlikely that depression may explain the observed associations.
Our results indicate that, in addition to lung function, anxiety may explain some of the variation in reported dyspnoea. However, whether anxiety causes dyspnoea or dyspnoea causes anxiety cannot be answered by the current study. An alternative explanation of our findings may be that the perception of dyspnoea differs among those with and without anxiety. Thus, anxiety may affect the reporting of dyspnoea. Still, when handling patients with obstructive lung diseases, treatment of both airway obstruction and anxiety, if present, are important in order to reduce the total symptom burden.
Methodological considerations
Due to the cross-sectional study design, we cannot draw conclusions about cause-and-effect relationships. 35 However, it is plausible to assume that reduced lung function or the condition causing it may cause dyspnoea, and not the other way around. Such assumptions cannot be drawn about the association between anxiety and dyspnoea as explained above. Further research on this topic should therefore be carried out in prospective study designs.
To overcome possible selection bias due to recruitment of subjects through the symptom or the random sample, we weighted the participants according to sample origin to imitate the characteristic properties of all participants in HUNT 2. Sensitivity analyses restricted to the random sample were comparable to the results of the weighted analyses though the small sample size gave imprecise results. In addition, the prevalence and mean of key variables in the weighted sample were very close to those in the random sample.
We studied lung function and anxiety in association with dyspnoea through the total range of lung function independent of possible diagnoses. However, in the supplementary analyses of COPD stages, 30% of people without COPD may have been misclassified as having COPD due to the use of pre-bronchodilator measurements. 36 Our study is one of few population-based studies assessing lung function and anxiety in association with dyspnoea. A major strength of our study is the large sample size with a wide age span. The response rate was relatively high. A nonresponder study did not indicate serious selection bias. 37 We believe our results are valid for the general population of Norway and other comparable countries.
Conclusion
Impaired lung function and anxiety symptoms were independently associated with reporting dyspnoea. Within lung function levels, reporting dyspnoea was more common among people with anxiety symptoms than among people without. This suggests that, in addition to its relation to reduced lung function, the subjective experience of breathing discomfort may also influence or be influenced by anxiety.
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